留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

虚燥更平散治疗女性更年期原发性高血压病临床研究

何佳 白永江 甘庆雷 林雪

何佳, 白永江, 甘庆雷, 林雪. 虚燥更平散治疗女性更年期原发性高血压病临床研究[J]. 南京中医药大学学报, 2013, 29(4): 327-330.
引用本文: 何佳, 白永江, 甘庆雷, 林雪. 虚燥更平散治疗女性更年期原发性高血压病临床研究[J]. 南京中医药大学学报, 2013, 29(4): 327-330.
HE Jia, BAI Yong-jiang, GAN Qing-lei, LIN Xue. Clinical Study of Xuzao Gengping Powder Treating Female Climactic Primary Hypertension[J]. Journal of Nanjing University of traditional Chinese Medicine, 2013, 29(4): 327-330.
Citation: HE Jia, BAI Yong-jiang, GAN Qing-lei, LIN Xue. Clinical Study of Xuzao Gengping Powder Treating Female Climactic Primary Hypertension[J]. Journal of Nanjing University of traditional Chinese Medicine, 2013, 29(4): 327-330.

虚燥更平散治疗女性更年期原发性高血压病临床研究

Clinical Study of Xuzao Gengping Powder Treating Female Climactic Primary Hypertension

  • 摘要: 目的 从动态血压观察虚燥更平散治疗女性更年期原发性高血压病的临床疗效。方法 选取2008年3月至2009年10月新疆维吾尔自治区中医院高血压科门诊就诊的92例更年期高血压病阴虚内燥证患者随机分成治疗组48例和对照组44例,分别于治疗前后进行24 h动态血压监测(ABPM),分析对血压变异及血压节律的影响。结果 ①与对照组比较,治疗组除24 h舒张压变异(24 hDSD)差异无统计学意义外(P>0.05),24 h收缩压变异(24 hSSD)、白天收缩压变异(dSSD)、白天舒张压变异(dDSD)、夜间收缩压变异(nSSD)、夜间舒张压变异(nDSD)均有统计学意义(P<0.05);②与对照组比较,治疗组平均血压除24 h平均舒张压(24 hDBP)、白天平均舒张压(dDBP)差异无统计学意义外(P>0.05),24 h平均收缩压(24 hSBP)、白昼平均收缩压(dSBP)、夜间平均舒张压(nDBP)、夜间平均收缩压(nSBP)均减小,有统计学意义(P<0.05);治疗组血压疗效总有效率高于对照组,有统计学意义(P<0.05)。夜间血压下降率明显上升,有统计学意义(P<0.05)。结论 虚燥更平散治疗更年期高血压病可调节血压节律,减小其血压变异性,明显降低收缩压水平,尤其对夜间血压变异的影响更为明显。

     

  • [1] 刘静,赵冬,王薇,等.中国多省市心血管病危险因素队列研究与美国弗莱明翰心脏研究结果的比较[J].中华心血管病杂志,2004,32(2):167-172.
    [2] Liu J, Zhao D, Wang W, et al. Comparision of Chinese cities cardiovascular disease risk factors study and American Framingham heart research[J]. Chin J Cardiol, 2004,32(2):167-172.
    [3] 王萍.新疆和静县部分牧民原发性高血压抽样调查[J].地方病通报,2006,21(6):95.
    [4] 〖JP2〗Wang P. Primary hypertension sample survey in part of Xinjiang and Jing county herders[J]. Dedem Dis Bull, 2006,21(6):95.〖JP〗
    [5] 朱宝珍,范世慧.二仙汤加减对更年期妇女高血压患者生活质量的影响[J].河北中医,2007, 29(1):80-81.
    [6] Zhu BZ, Fan SH. Effect of Erxian Decoction modified on life quality of female climactic hypertension patients[J]. Hebei Tradit Chin Med, 2007:29(1):80-81.
    [7] 张盛群,聂祥碧,张萍.不同分期老年高血压患者血压变异观察[J].贵州医药, 1999,23(3):176.
    [8] Zhang SQ, Nie XB, Zhang P. Research on different-period blood pressure variation of elderly patients with hypertension[J]. Guizhou Med J, 1999,23(3):176.
    [9] 李国钰,曹艳君.血压变异与临床意义心血管病学进展[J].心血管病学进展,2004,25(12):29-31.
    [10] Li GY, Cao YQ. Blood pressure and clinical cardiology progress[J]. Advances in Cardiovascular Diseases, 2004,25(12):29-31.
    [11] 李南方,周玲,曹梅,等.新疆和丰县牧区高血压病流行病学调查报告[J].现代预防医学,2003,30(2):141-143.
    [12] Li NF, Zhou L, Cao M, et al. Survey report of hypertension epidemiology in Xinjiang and Feng County pastoral areas[J]. Modern Prevent Med, 2003,30(2):141-143.
    [13] 刘力生.中国高血压防治指南[M].北京:人民卫生出版社,2005:3-4.
    [14] Liu LS. Prevention guide of Chinese hypertension[M]. Beijing:People's medical publishing house,2005:3-4.
    [15] 张惜阴.实用妇产科学[M].北京:人民卫生出版社,2004:76-77.
    [16] Zhang XY. Practical of obstetrics & gynecology[M]. Beijing:People's medical publishing house, 2004:76-77.
    [17] 周铭心.西北燥证证候类型分析[J].新疆医科大学学报,2007,30(1):1-6.
    [18] Zhou MX. Analysis of northwestern dryness syndrome types[J]. J Xinjiang Med Univ, 2007,30(1):1-6.
    [19] 中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002:29-31.
    [20] Clinical guideline of new drugs for traditional Chinese medicine[S]. Beijing: China medical science press, 2002:29-31.
    [21] Gu d, Wildman PR, Wu X,et al. Incidence and predictors of hypertension over 8 years among Chinese menand women[J].J Hy-pertens,2007,25(3):517-523.
    [22] Parati G, Faini A, Valentini M.Blood pressure variability: its measurement and significance in hypertension[J].CurrHypertensRep, 2006,8:199-204.
    [23] Blanco F, Gil P, Arco CD, et al. Association of clinic and ambulatorblood pressure with vascular damage in the elderly: the EPICARDIAN study[J]. Blood Press Monit, 2006,11(6): 329-335.
    [24] Hansen TW, Thijs L, Li Y,et al. Prognostic value of short-termblood pressure variability over 24 hours in 8937 subjects from 11 opulations[J].Hypertension,2010,55(4):1049-1057.
    [25] de Simone G, Wachtell K, Palmieri V,et al. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study[J].Circulation,2005,111(15):1924-1931.
    [26] 林雪,尚玉红,杨娜.刘继祖治疗更年期女性高血压经验[J].新疆中医药,2006,24(2):34-35.
    [27] Lin X, Shang YH, Yang N. Liu Jizu's experience of treating female climactic hypertension[J]. Xingjiang J Tradit Chin Med, 2006,24(2):34-35.
  • 加载中
计量
  • 文章访问数:  650
  • HTML全文浏览量:  7
  • PDF下载量:  635
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-02-20
  • 修回日期:  2013-04-11
  • 刊出日期:  2013-07-10

目录

    /

    返回文章
    返回